Global Financial Private Client’s iShares Dow Jones US ETF IYY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30
Closed -$4.08K 905
2025
Q1
$4.08K Hold
30
﹤0.01% 722
2024
Q4
$4.29K Hold
30
﹤0.01% 651
2024
Q3
$4.19K Hold
30
﹤0.01% 666
2024
Q2
$3.97K Hold
30
﹤0.01% 522
2024
Q1
$3.83K Hold
30
﹤0.01% 542
2023
Q4
$3.5K Hold
30
﹤0.01% 547
2023
Q3
$3.13K Hold
30
﹤0.01% 538
2023
Q2
$3.25K Hold
30
﹤0.01% 536
2023
Q1
$3.01K Hold
30
﹤0.01% 545
2022
Q4
$2.8K Hold
30
﹤0.01% 535
2022
Q3
$2.7K Hold
30
﹤0.01% 511
2022
Q2
$2.8K Hold
30
﹤0.01% 491
2022
Q1
$3.35K Hold
30
﹤0.01% 493
2021
Q4
$3.54K Hold
30
﹤0.01% 478
2021
Q3
$3.27K Hold
30
﹤0.01% 429
2021
Q2
$3.25K Hold
30
﹤0.01% 436
2021
Q1
$3.03K Hold
30
﹤0.01% 394
2020
Q4
$2.83K Hold
30
﹤0.01% 390
2020
Q3
$2.52K Hold
30
﹤0.01% 382
2020
Q2
$2.31K Hold
30
﹤0.01% 434
2020
Q1
$1.81K Hold
30
﹤0.01% 456
2019
Q4
$2.4K Buy
+30
New +$2.29K ﹤0.01% 464

Other funds holding IYY

Global Financial Private Client's IYY Position: Q2 2025 in Review

Global Financial Private Client sold out of iShares Dow Jones US ETF (IYY) in Q2 2025, closing a stake of 30 shares — an estimated $4.08K sold.

Global Financial Private Client first reported a position in IYY in Q4 2019 and held it in 22 quarters. The position peaked at $4.29K in Q4 2024. 258 funds tracked by Wall St. Rank hold IYY as of Q2 2025.

  • Global Financial Private Client reported no remaining iShares Dow Jones US ETF position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 30 iShares Dow Jones US ETF shares in Q2 2025, an estimated $4.08K.
  • Global Financial Private Client first reported a position in iShares Dow Jones US ETF in Q4 2019 and held it in 22 quarters.
  • Global Financial Private Client's iShares Dow Jones US ETF position peaked at $4.29K in Q4 2024.
  • 258 funds tracked by Wall St. Rank held iShares Dow Jones US ETF as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.